Antibody-Based Biotherapeutics in Migraine
Author:
Publisher
Springer International Publishing
Link
https://link.springer.com/content/pdf/10.1007/978-3-031-30023-3_26
Reference21 articles.
1. Al-Hassany L, MaassenVanDenBrink A (2021) Drug interactions and risks associated with the use of triptans, ditans and monoclonal antibodies in migraine. Curr Opin Neurol 34(3):330–338. https://doi.org/10.1097/WCO.0000000000000932
2. Cohen JM, Ning X, Kessler Y, Rasamoelisolo M, Campos VR, Seminerio MJ, Krasenbaum LJ, Shen H, Stratton J (2021) Immunogenicity of biologic therapies for migraine: a review of current evidence. J Headache Pain 22(1):3. https://doi.org/10.1186/s10194-020-01211-5
3. Cohen F, Yuan H, Silberstein SD (2022) Calcitonin gene-related peptide (CGRP)-targeted monoclonal antibodies and antagonists in migraine: current evidence and rationale. BioDrugs 36(3):341–358. https://doi.org/10.1007/s40259-022-00530-0
4. Edvinsson L (2021) CGRP and migraine: from bench to bedside. Rev Neurol (Paris) 177(7):785–790. https://doi.org/10.1016/j.neurol.2021.06.003
5. Edvinsson L (2022) Calcitonin gene-related peptide (CGRP) is a key molecule released in acute migraine attacks-successful translation of basic science to clinical practice. J Intern Med 292(4):575–586. https://doi.org/10.1111/joim.13506
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3